The increase in the risk of developing breast cancer among women with type 2 diabetes and diminished estrogen levels due to insulin resistance elevates the risk of cancer in estrogen receptor-rich organs such as the breasts, endometrium, and ovaries. This evidence concerns the gene ESR1 and breast cancer.